Parallax Volatility Advisers
GNMK

Parallax Volatility Advisers’s GenMark Diagnostics, Inc GNMK Stock Holding History

Parallax Volatility Advisers’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-7,686
Closed -$32K – 4874
2017
Q4 		$32K Buy
+7,686
New +$46.3K ﹤0.01% 3468

Other funds holding GNMK

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Parallax Volatility Advisers's GNMK Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2018, closing a stake of 7,686 shares — an estimated $32K sold.

Parallax Volatility Advisers first reported a position in GNMK in Q4 2017 and held it in 1 quarter. The position peaked at $32K in Q4 2017. 98 funds tracked by Wall St. Rank hold GNMK as of Q1 2018.

  • Parallax Volatility Advisers reported no remaining GenMark Diagnostics, Inc position as of Q1 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 7,686 GenMark Diagnostics, Inc shares in Q1 2018, an estimated $32K.
  • Parallax Volatility Advisers first reported a position in GenMark Diagnostics, Inc in Q4 2017 and held it in 1 quarter.
  • Parallax Volatility Advisers's GenMark Diagnostics, Inc position peaked at $32K in Q4 2017.
  • 98 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.